Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

NCT06394427 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT06394427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06394427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA- N2IIIB Non-small Cell Lung Cancer
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2024
Completion date
August 31, 2025
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer stage iiib, non-small cell lung cancer stage Ⅲa